WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV clinical research development services and Bioequivalence (BE) studies for products including pharmaceuticals, biologics, and medical devices. With expertise spanning across all major therapeutic areas, we deliver the unique blend of an experienced team and a highly nimble organization. Our forward-thinking approach has allowed us together with our clients to swiftly market inventive medical products to patients around the world.